Cargando…

A new scoring system in Cystic Fibrosis: statistical tools for database analysis – a preliminary report

BACKGROUND: Cystic fibrosis is the most common fatal genetic disorder in the Caucasian population. Scoring systems for assessment of Cystic fibrosis disease severity have been used for almost 50 years, without being adapted to the milder phenotype of the disease in the 21(st )century. The aim of thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hafen, GM, Hurst, C, Yearwood, J, Smith, J, Dzalilov, Z, Robinson, PJ
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2580762/ https://www.ncbi.nlm.nih.gov/pubmed/18834547 http://dx.doi.org/10.1186/1472-6947-8-44

Ejemplares similares

Scoring tools to monitor risk of disease progression in patients with cystic fibrosis
por: Donadio, Márcio Vinícius Fagundes, et al.
Publicado: (2020)

No benefit of longer eradication therapy of Pseudomonas aeruginosa primoinfections in pediatric cystic fibrosis
por: Claude, F., et al.
Publicado: (2019)

Microbiota Present in Cystic Fibrosis Lungs as Revealed by Whole Genome Sequencing
por: Hauser, Philippe M., et al.
Publicado: (2014)

Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report.
por: Sermet-Gaudelus, I, et al.
Publicado: (1999)

Cardiopulmonary Exercise Testing: Another Tool in the Prognostication Tool Kit for Cystic Fibrosis
por: Ramos, Kathleen J.
Publicado: (2019)

Saliva as a potential tool for cystic fibrosis diagnosis
por: Gonçalves, Aline Cristina, et al.
Publicado: (2013)

Cystic Fibrosis
por: Dodge, J A
Publicado: (1997)

Investigation of host and pathogen responses to estrogen in cystic fibrosis
por: Mulla, Moyser, et al.
Publicado: (2013)

Serum Level of D-Lactate in Patients with Cystic Fibrosis: Preliminary Data
por: Więcek, Sabina, et al.
Publicado: (2018)

Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening
por: Vaccarin, Christian, et al.
Publicado: (2022)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
por: Schmidt, Béla Z, et al.
Publicado: (2016)

Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools()
por: Scott, Jennifer A., et al.
Publicado: (2023)

PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis
por: Noel, Sabrina, et al.
Publicado: (2012)

Gene therapy for cystic fibrosis: new tools for precision medicine
por: Lee, Jin-A, et al.
Publicado: (2021)

The Microbiome in Cystic Fibrosis
por: Huang, Yvonne J., et al.
Publicado: (2016)

Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study
por: Amato, Felice, et al.
Publicado: (2021)

Preliminary national report on cystic fibrosis epidemiology in Tunisia: the actual state of affairs
por: Hamouda, Samia, et al.
Publicado: (2020)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Shwachman-Kulczycki score still useful to monitor cystic fibrosis severity
por: Stollar, Fabíola, et al.
Publicado: (2011)

Prevalence of Anemia and its Relation with Shwachman Score in Children with Cystic Fibrosis
por: Afifi, Mona, et al.
Publicado: (2023)

Patient and family perceptions of telehealth as part of the cystic fibrosis care model during COVID-19
por: Davis, J., et al.
Publicado: (2021)

Cystic Fibrosis
por: Gibson, Lewis E.
Publicado: (1969)

Comparing cystic fibrosis outcomes across the pond
por: Taylor-Robinson, David C, et al.
Publicado: (2015)

The measurement properties of tests and tools used in cystic fibrosis studies: a systematic review
por: McLeod, Charlie, et al.
Publicado: (2021)

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
por: Quittner, Alexandra L, et al.
Publicado: (2016)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin, David A, et al.
Publicado: (2013)

Assessment of the Non-Cystic Fibrosis Bronchiectasis Severity: The FACED Score vs the Bronchiectasis Severity Index
por: Minov, J, et al.
Publicado: (2015)

Higher Mobility Scores in Patients with Cystic Fibrosis Are Associated with Better Lung Function
por: Thobani, Aneesha, et al.
Publicado: (2015)

Role of vitamin D in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Moustaki, Maria, et al.
Publicado: (2017)

When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients
por: Faro, Albert, et al.
Publicado: (2022)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016)

How are the ancient cystic fibrosis patients? Cystic fibrosis diagnosed over 60 years-old
por: Prados, C., et al.
Publicado: (2017)

Rapid early increase in BMI is associated with impaired longitudinal growth in children with cystic fibrosis
por: Hak, Sarah F., et al.
Publicado: (2019)

Glucose Tolerance during Pulmonary Exacerbations in Children with Cystic Fibrosis
por: Widger, John, et al.
Publicado: (2012)

Shared Decision-Making Tool for Self-Management of Home Therapies for Patients With Cystic Fibrosis
por: Eckman, Mark H., et al.
Publicado: (2017)

Coexistence of cystic fibrosis and phenylketonuria.
por: Greeves, L. G., et al.
Publicado: (1997)

Home videos of cystic fibrosis patients using tobramycin inhalation powder: Relation of flow and cough
por: Meerburg, Jennifer J., et al.
Publicado: (2019)

Prevalence of Pelvic Incontinence in Patients With Cystic Fibrosis
por: Neemuchwala, Fatima, et al.
Publicado: (2017)

Cystic fibrosis modulator therapy can reverse cystic bronchiectasis
por: Middleton, Peter G., et al.
Publicado: (2023)

Utilisation, expenditure and cost-effectiveness of cystic fibrosis drugs in Ireland: a retrospective analysis of a national pharmacy claims database
por: Smith, Amelia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7iglcha34att7s1emm0t8rudk2